Immuneering Corp Contracts & Agreements
30 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (3)
- Human Resources (16)
- Real Estate (1)
- Uncategorized (3)
- Immuneering Corporation Non-Employee Director Compensation Program, as amended (Filed With SEC on August 6, 2024)
- Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective January 1, 2024 (Filed With SEC on March 1, 2024)
- Employment Agreement, dated March 24, 2023, by and between Harold E. Brakewood and Immuneering Corporation (Filed With SEC on March 1, 2024)
- Letter Agreement, dated June 14, 2023, by and between Mallory Morales and Immuneering (Filed With SEC on March 1, 2024)
- Employment Agreement, dated July 23, 2021, by and between Mallory Morales and Immuneering Corporation (Filed With SEC on March 1, 2024)
- Separation Agreement and Relea (Filed With SEC on November 9, 2023)
- Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective (Filed With SEC on November 9, 2023)
- Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective (Filed With SEC on August 3, 2023)
- Underwriting Agreement, dated as of April 18, 2023, by and among Immuneering Corporation, Jefferies LLC, Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on April 19, 2023)
- Letter Agreement, by and between Immuneering Corporation and Mallory Morales, dated as of July 25, 2022 (Filed With SEC on July 25, 2022)
- Description of Securities (Filed With SEC on March 10, 2022)
- Lease Agreement, by and between BioArkive, Inc, and Thornmint 13, LLC, dated as of July 22, 2021 (Filed With SEC on December 22, 2021)
- Share Purchase Agreement by and among Immuneering Corporation, BioArkive, Inc. and BioArkives shareholders, dated as of December 22, 2021 (Filed With SEC on December 22, 2021)
- Form of Indemnification Agreement by and among the Registrant and its directors and officers (Filed With SEC on July 26, 2021)
- Immuneering Corporation Non-Employee Director Compensation Program (Filed With SEC on July 26, 2021)
- Immuneering Corporation 2021 Employee Stock Purchase Plan (Filed With SEC on July 26, 2021)
- Immuneering Corporation 2021 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on July 26, 2021)
- Employment Letter Agreement, dated July 23, 2021 by and between Michael D. Bookman and the Registrant (Filed With SEC on July 26, 2021)
- Employment Letter Agreement, dated July 23, 2021 by and between Benjamin J. Zeskind, Ph.D. and the Registrant (Filed With SEC on July 26, 2021)
- Employment Letter Agreement, dated July 23, 2021, by and between Scott Barrett, M.D. and the Registrant (Filed With SEC on July 26, 2021)
- Employment Letter Agreement, dated July 23, 2021, by and between Brett Hall, Ph.D. and the Registrant (Filed With SEC on July 26, 2021)
- Employment Letter Agreement, dated July 23, 2021, by and between Biren Amin and the Registrant (Filed With SEC on July 26, 2021)
- Amended and Restated Investors Rights Agreement, as amended, dated December 21, 2020, byand among the Registrant and the other parties thereto (Filed With SEC on July 26, 2021)
- Specimen Stock Certificate evidencing the shares of Class A common stock (Filed With SEC on July 26, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 26, 2021)
- Amended and Restated Investors Rights Agreement, dated December 21, 2020, by and among the Registrant and the other parties thereto (Filed With SEC on July 9, 2021)
- Immuneering Corporation Long Term Incentive Plan and form of option agreement thereunder (Filed With SEC on July 9, 2021)
- Immuneering Corporation 2008 Stock Incentive Plan and form of option agreement thereunder (Filed With SEC on July 9, 2021)
- Advisory Agreement, dated September 17, 2019, by and between PEF LLC and the Registrant (Filed With SEC on July 9, 2021)
- Master Services Agreement, dated August 5, 2019, by and between Bioarkive LLC and the Registrant (Filed With SEC on July 9, 2021)
